These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25773221)

  • 1. Neuronal hyperactivity--A key defect in Alzheimer's disease?
    Busche MA; Konnerth A
    Bioessays; 2015 Jun; 37(6):624-32. PubMed ID: 25773221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairments of neural circuit function in Alzheimer's disease.
    Busche MA; Konnerth A
    Philos Trans R Soc Lond B Biol Sci; 2016 Aug; 371(1700):. PubMed ID: 27377723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Storm before the quiet: neuronal hyperactivity and Aβ in the presymptomatic stages of Alzheimer's disease.
    Stargardt A; Swaab DF; Bossers K
    Neurobiol Aging; 2015 Jan; 36(1):1-11. PubMed ID: 25444609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Ca
    Lerdkrai C; Asavapanumas N; Brawek B; Kovalchuk Y; Mojtahedi N; Olmedillas Del Moral M; Garaschuk O
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1279-E1288. PubMed ID: 29358403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
    Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
    Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.
    Nobili A; Latagliata EC; Viscomi MT; Cavallucci V; Cutuli D; Giacovazzo G; Krashia P; Rizzo FR; Marino R; Federici M; De Bartolo P; Aversa D; Dell'Acqua MC; Cordella A; Sancandi M; Keller F; Petrosini L; Puglisi-Allegra S; Mercuri NB; Coccurello R; Berretta N; D'Amelio M
    Nat Commun; 2017 Apr; 8():14727. PubMed ID: 28367951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.
    Chakroborty S; Stutzmann GE
    Sci China Life Sci; 2011 Aug; 54(8):752-62. PubMed ID: 21786198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Yu D; Tao BB; Yang YY; Du LS; Yang SS; He XJ; Zhu YW; Yan JK; Yang Q
    J Alzheimers Dis; 2015; 43(1):291-302. PubMed ID: 25079795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease.
    Zilberter M; Ivanov A; Ziyatdinova S; Mukhtarov M; Malkov A; Alpár A; Tortoriello G; Botting CH; Fülöp L; Osypov AA; Pitkänen A; Tanila H; Harkany T; Zilberter Y
    J Neurochem; 2013 Apr; 125(1):157-71. PubMed ID: 23241062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
    Faivre E; Hölscher C
    J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral treatment with a gamma-secretase inhibitor improves long-term potentiation in a mouse model of Alzheimer's disease.
    Townsend M; Qu Y; Gray A; Wu Z; Seto T; Hutton M; Shearman MS; Middleton RE
    J Pharmacol Exp Ther; 2010 Apr; 333(1):110-9. PubMed ID: 20056779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    Moon M; Cha MY; Mook-Jung I
    J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network excitability dysfunction in Alzheimer's disease: insights from in vitro and in vivo models.
    Santos SF; Pierrot N; Octave JN
    Rev Neurosci; 2010; 21(3):153-71. PubMed ID: 20879690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
    Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
    Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic degeneration in Alzheimer's disease.
    Arendt T
    Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein receptors in Alzheimer's disease.
    Andersen OM; Willnow TE
    Trends Neurosci; 2006 Dec; 29(12):687-94. PubMed ID: 17000013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
    Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
    J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.